The US Centers for Disease Control and Prevention (CDC) has launched a campaign to raise awareness about chronic fatigue syndrome among doctors and patients. The agency's initiative comes amid skepticism from many in the US medical profession that the disease exists and perceived indifference from drugmakers.
The medical community and drugmakers are limited by the difficulty in identifying the cause of the syndrome. Nancy Klimas, a researcher at the university of Miami University, in Florida, USA, told the WebMD on-line medical magazine that "there's no diagnostic test, no blood test." However, the CDC cites recent studies which found abnormalities in the human body's autonomic nervous system and possible genetic markers that may cause the body to overreact to stress.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze